Tissue repair signalling: BPC-157 and TB-500 in the literature

BPC-157 is a synthetic pentadecapeptide derived from a sequence in human gastric juice. In rodent models it has been associated with accelerated healing across tendon, muscle, gut and vascular tissue, with proposed mechanisms including upregulated growth-factor receptor expression, nitric-oxide pathway involvement and promotion of angiogenesis. TB-500 corresponds to the active region of thymosin beta-4, an actin-sequestering peptide involved in cell migration and wound closure. Preclinical work describes effects on angiogenesis, cell motility and inflammatory resolution. Both bodies of literature are broad and mostly animal-based. Controlled human trials are limited, which means the current status of each compound is preclinical signal rather than demonstrated clinical benefit — a useful position for laboratory research, and not a basis for claims.